BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9126213)

  • 41. A look at Pap test accuracy and the duty to inform from a risk management perspective.
    Meister S
    QRC Advis; 1997 Dec; 14(2):1, 5-8. PubMed ID: 10176015
    [No Abstract]   [Full Text] [Related]  

  • 42. The Pap smear is a cancer screening test: why not put the screening error rate in the report?
    Robb J
    Diagn Cytopathol; 1993 Oct; 9(5):485-6. PubMed ID: 8054009
    [No Abstract]   [Full Text] [Related]  

  • 43. The Pap smear: take two.
    Shulman JJ; Hontz A; Sedlis A; Walters AT; Balin H; LoScuito L
    Am J Obstet Gynecol; 1975 Apr; 121(8):1024-8. PubMed ID: 1119496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cervical cancer screening: the Pap smear. Summary of an NIH consensus statement.
    Br Med J; 1980 Nov; 281(6250):1264-6. PubMed ID: 7427661
    [No Abstract]   [Full Text] [Related]  

  • 45. Screening for cervical cancer using automated analysis of PAP-smears.
    Bengtsson E; Malm P
    Comput Math Methods Med; 2014; 2014():842037. PubMed ID: 24772188
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Problems and progress with Pap smear screening reviewed.
    Volkers N
    J Natl Cancer Inst; 1992 Nov; 84(22):1694-5. PubMed ID: 1433354
    [No Abstract]   [Full Text] [Related]  

  • 47. Breast and cervical cancer screening utilization among Hispanic women living near the United States-Mexico border.
    Nuño T; Castle PE; Harris R; Estrada A; García F;
    J Womens Health (Larchmt); 2011 May; 20(5):685-93. PubMed ID: 21428792
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The false negative rate in cervical cytology. Comparison of monolayers to conventional smears.
    Sprenger E; Schwarzmann P; Kirkpatrick M; Fox W; Heinzerling RH; Geyer JW; Knesel EA
    Acta Cytol; 1996; 40(1):81-9. PubMed ID: 8604579
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liquid-based cytology test use by office-based physicians: United States, 2006-2007.
    Hing E; Saraiya M; Roland KB
    Natl Health Stat Report; 2011 Jun; (40):1-6. PubMed ID: 21692417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cervical carcinoma in situ undetected by Papanicolaou smear but identified by cervicography. A case report.
    Ferris DG
    J Fam Pract; 1994 Jan; 38(1):74-7. PubMed ID: 8289055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison.
    Chacho MS; Mattie ME; Schwartz PE
    Cancer; 2003 Jun; 99(3):135-40. PubMed ID: 12811853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Should U.S. women be screened for cervical cancer with pap tests, HPV tests, or both?
    Perkins RB; Stier EA
    Ann Intern Med; 2014 Aug; 161(4):295-7. PubMed ID: 24912666
    [No Abstract]   [Full Text] [Related]  

  • 53. [Papanicolau smears: reducing the false negative rate by improving the method].
    Biran G; Levy T
    Harefuah; 2004 Mar; 143(3):217-21, 245. PubMed ID: 15065363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Annual colposcopies and pap smears recommended for women with HIV.
    Highleyman L
    BETA; 1999 Apr; 12(2):6. PubMed ID: 11366700
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Making the Pap smear into the "right tool" for the job.
    Casper MJ; Clarke AE
    Soc Stud Sci; 1998 Apr; 28(2):255-90. PubMed ID: 11620085
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exfoliative cytologic screening. The Papanicolaou test.
    Ginsberg CK
    J Obstet Gynecol Neonatal Nurs; 1991; 20(1):39-46. PubMed ID: 2005483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology.
    Budge M; Halford J; Haran M; Mein J; Wright G
    Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):215-9. PubMed ID: 15904447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cervical cancer screening among elderly urban women in a primary care setting.
    Wong QC; Collins R; Kalkstein K; Roth A; Gintautas J
    Proc West Pharmacol Soc; 2005; 48():154-6. PubMed ID: 16416686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The gynecologist's perspective of liability and quality issues with the Papanicolaou smear.
    Greer BE
    Arch Pathol Lab Med; 1997 Mar; 121(3):246-9. PubMed ID: 9111109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current cervical cancer screening practices of Dane County, Wisconsin primary care clinicians.
    Marchand L; Van Dinter M; Mundt M; Dingel W; Klein G
    WMJ; 2003; 102(3):35-40. PubMed ID: 12822288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.